Copyright
©The Author(s) 2025.
World J Gastrointest Oncol. Apr 15, 2025; 17(4): 103455
Published online Apr 15, 2025. doi: 10.4251/wjgo.v17.i4.103455
Published online Apr 15, 2025. doi: 10.4251/wjgo.v17.i4.103455
Table 6 Comprehensive comparison of staging systems for gastric cancer and esophageal adenocarcinoma in adenocarcinoma of the esophagogastric junction patients
Project | Likelihood ratio χ2 price | Linear trend χ2 price | The log-likelihood estimate | |||
Gastric cancer TNM staging system | Esophageal cancer TNM staging system | Gastric cancer TNM staging system | Esophageal cancer TNM staging system | Gastric cancer TNM staging system | Esophageal cancer TNM staging system | |
Type E | 10.896 | 6.615 | 3.327 | 5.178 | 37.018 | 37.300 |
Type Eg | 17.032 | 18.760 | 11.923 | 9.899 | 55.624 | 62.748 |
Type Ge | 13.514 | 7.575 | 2.873 | 1.196 | 181.106 | 186.322 |
- Citation: Guo S, Liu FF, Yuan L, Ma WQ, Er LM, Zhao Q. Subclassification scheme for adenocarcinomas of the esophagogastric junction and prognostic analysis based on clinicopathological features. World J Gastrointest Oncol 2025; 17(4): 103455
- URL: https://www.wjgnet.com/1948-5204/full/v17/i4/103455.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v17.i4.103455